Monthly Meeting
Bulgaria Meets the UK: Best Practice Exchange Webinar on Children's Hospital Care
Thank you very much for taking part in: Bulgaria Meets the UK: Best Practice Exchange Webinar on Children's Hospital Care. As a follow up, we'd like to share with you video recording of the webinar:
We would like to thank all the panellists from the UK and Bulgaria, who shared their experience and exchanged best practices. Should you wish to continue your conversation with some of the panellists, please let us know at office@bbba.bg and we will be happy to put you in touch.
Special thanks to the British Embassy Sofia and the Health & Life Sciences Cluster who in cooperation with the British Bulgarian Business Association made this event happen.
This webinar was broadcasted and delivered by the support of Premium Coworking Spaces.
VIDEO
CONTENT
11:00-11:10 – Opening Speech
HMA Dr. Rob Dixon, British Embassy Sofia
11:10-11:20 – Ms. Jeny Nacheva, Ph.D., Deputy Health Minister, Bulgarian Ministry of Health
11:20-11:40 – Mr. Crispin Walkling-Lea, Head of Healthcare Planning, Great Ormond Street Hospital, London
11:40-12:00 – Ms. Angie May, International Partnerships Lead, Dept. of International Child Health, Alder Hey Hospital, Liverpool
12:00-12:15 – Mr. Doncho Barbalov, Deputy Mayor for Finance and Healthcare, Sofia Municipality
12:15-13:10 – Q&A session and discussion
THE PANEL PARTICIPANTS
Prof. Ivan Ivanov – Head of Clinic, Medical University of Plovdiv and St. George University Hospital
Ms. Assya Pascalev, Ph.D. – Executive Director, Bulgarian Center for Bioethics
Dr. Dimitar Georgiev, MD – Bulgarian Association for Personalized Medicine
Dr. Plamen Mitev, MD – Pediatric Surgeon, Manager of Health Hospital and Children's Health Medical Center, Sofia
Prof. Dr. Violeta Iotova, PhD – Dept.of Paediatrics, MUV - Head, First Pediatric Endocrinology with ICU - Head, UMHAT "St. Marina"
Mr. Martin Shiderov – Head of Healthcare and Life Sciences, Investment Services Team at EY, London, UK
Dr. Armine Grigoryan – Medical University Pleven
Dr. Emil Slavov – Trakia University
Prof. Vladimir Pilossof – Chairman of Board, Bulgarian Pediatric Association
Moderators in studio: Deyan Blagoev & Kristina Eskenazi
Innovative and proficient integrated Health & Life Science ecosystem
We promote an innovative and dynamic environment for the Health & Biotech industry in Bulgaria.
Health & Life Sciences Cluster Bulgaria ecosystem comprises several stakeholders from academia, the public sector, and the private sector. The principal idea is to facilitate open collaboration and to accelerate innovation by bringing together various partners able to contribute to the needs of the health care sector. The ecosystem approach enables the combination of expertise from wireless information technologies and life science to introduce smart ICT solutions for delivering advanced, personalized, connected health service solutions.
Agricultural biotech
For centuries, farmers gradually improved their crops. Today, modern agricultural biotechnology allows us to improve them in more targeted ways, and give plant varieties desirable characteristics, such as resistance to certain pests or herbicides, enhanced robustness against diseases, drought or water tolerance, or healthier profiles that can enhance nutrition.
Healthcare biotech
Healthcare biotechnology is used to create an advanced class of drugs and therapies called biologics, such as gene and stem cell therapies, but also vaccines and diagnostic tools such as HIV test kits. Medical devices. ICT Health solutions.
Industrial Biotech
Industrial biotechnology uses enzymes and micro-organisms to make biobased products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and bioenergy. In doing so, it uses renewable raw materials and is one of the most promising, innovative approaches towards lowering greenhouse gas emissions.
Cross sector
In addition to priorities in the healthcare, industrial and agricultural biotech sectors, Health & Life Sciences Cluster works on a number of industry-wide initiatives to strengthen biotechnology in Bulgaria. These include intellectual property, SMEs and outreach projects to raise the profile of Bulgarian biotech among policymakers and the general public.